Just down rampers, people dont forget that there were people thinking here that it was bad news
The extra Psilocyibin that has been received is seen as a massive barrier to people within this industry / our competitors. Hallucenex is now the largest holder of Psilocybin in Canada putting CPH greatly infront of its competitors within the Psychadelic treatment industry.
Thats why its price sensitive imo. Big head start for us over peers.
Hallucenex is now massively derisked, just awaiting the dealers license now. R&D continues.
OTC US listing also expected imminently, i assume we are just waiting on the regluatory parties now to accept.
All in All im happy that this is news in the RIGHT direction and not the opposite that others were fearing.
GLTAH.
CPH Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
